香港股市 已收市

Novavax, Inc. (NVAX)

NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
4.7800-0.0700 (-1.44%)
收市:04:00PM EDT
4.7600 -0.02 (-0.42%)
收市後: 07:58PM EDT
全螢幕
交易股價資料並非來自所有市場
前收市價4.8500
開市4.8400
買盤4.7400 x 200
賣出價4.7900 x 200
今日波幅4.7600 - 4.9450
52 週波幅3.5300 - 11.3600
成交量3,609,629
平均成交量8,628,157
市值668.975M
Beta 值 (5 年,每月)1.58
市盈率 (最近 12 個月)
每股盈利 (最近 12 個月)-5.4100
業績公佈日2024年5月07日 - 2024年5月13日
遠期股息及收益率無 (無)
除息日
1 年預測目標價15.40
  • Zacks

    Moderna (MRNA) Posts Upbeat Data From Next-Gen COVID Jab Study

    Data from a late-stage study shows that Moderna's (MRNA) next-generation COVID vaccine induces a more robust immune response compared with its previously approved bivalent COVID vaccine.

  • Motley Fool

    1 Beaten-Down Stock That's Still Not Worth Buying

    For this biotech, a rebound seems far too unlikely.

  • InvestorPlace

    7 Short-Squeeze Stocks That Could Send the Bears Into Panic-Mode

    There’s a simple reason why short-squeeze stocks to buy represent a powerful catalyst: they’re intuitive and easier to engage. Buying something and hoping that it appreciates in value represents an organically sensible strategy. It’s the reason why people collect everything from baseball cards to luxury Swiss watches. Stated differently, it doesn’t take much to explain the rationale behind short-squeeze stocks to buy. On the other hand, shorting a stock represents an incredibly complex affair by